Combination of Superficial and Deep Blocks with Rivaroxaban.

摘要: Objective Rivaroxaban is a new Xa inhibitor indicated for thromboprophylaxis in patients undergoing joint arthroplasty. This study was designed to assess the risk of major bleeding from combination either single or continuous deep, superficial, and plexus block use rivaroxaban following arthroplasty. Method Patients primary, redo, unilateral, bilateral total hip knee replacement while receiving femoral, sciatic, lumbar nerve alone at least one dose 10 mg once day postoperatively were included this analysis. Results In series, 766 (199 replacements 567 replacements) included. A 1,104 blocks performed including 1,029 (509 320 200 plexus). No related performance peripheral recorded. In contrast, three developed hematomas operated requiring surgical evacuation. Minor recorded site 12 vs block. Although all minor occurred after initiation therapy, 80% before thromboprophylaxis. Conclusion Our data supports concept that there no increased when deep superficial are